observational cohort and interventional studies · 2018-07-11 · – community interventions...

104
Observational Cohort and Interventional Studies Health and Service Needs of the Elderly in Singapore NMRC Research Symposium 2015 - Health Services Research (18 March 2015) Ng Tze Pin Principal Investigator, Singapore Longitudinal Ageing Studies Research Director, Gerontological Research Programme, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore

Upload: others

Post on 06-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Observational Cohort and Interventional Studies

Health and Service Needs of the Elderly in Singapore

NMRC Research Symposium 2015 - Health Services Research (18 March 2015)

Ng Tze Pin

Principal Investigator, Singapore Longitudinal Ageing Studies

Research Director, Gerontological Research Programme,

Department of Psychological Medicine, Yong Loo Lin School of Medicine,

National University of Singapore

Page 2: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aims and Outline

1. Highlight major areas of research on health and

service needs and interventions for the elderly in

Singapore

2. Present findings of observational and interventional

studies in the Gerontology Research Programme

– Physical Disability and Frailty

– Cognitive Impairment and Dementia

– Depression

3. Indicate future areas and directions of health

service research

Page 3: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborations and Partnerships

Council for the Third Age (C3A), Geylang East Home for the Aged, Presbyterian Community Services, Thye Hua Kwan

Moral Society, NTUC Eldercare Co-op Ltd

Research

Translation

Dissemination

• A programme of research that aims to:

• To increase current understanding of aging and health transition

• providing the scientific information needed for formulating strategies of

disease prevention and health promotion in the elderly

Observational Cohort and Interventional Studies

Page 4: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

SLAS-1: N=2808 South East Region

Aged 55+

SLAS-2: N=3,200 South Central Region

South West Region

Aged 55+

Baseline: 2003-4

Follow ups: 2007-2008;

2010-2011

Mortality follow-up till 2010:

mean 6 years

Baseline: 2009-2010

Follow-up: 2012-ongoing

Singapore Longitudinal Ageing Studies (2004 – 2015)

SLAS-3: N=2,000 Island wide

Aged 80+

Commencing 2015

Page 5: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Domains Measurements

Psychosocial Biodata, social network & support, work and retirement

Lifestyle and

behavior

Lifestyle and behaviour: smoking, alcohol, coffee, tea, curry, mobile phone,

computer use, Leisure-time activities,

Medical,

biological,

physiological

Medical history, medications, adherence, supplements, health service use

(doctor visits, hospitalization)

BP, ECG, COPD Questionnaire, BORG dyspnea scale, Spirometry (pre- and

post-bronchodilator), Logmar, Retinal Photography

Blood: fasting glucose, lipids, homocysteine, haematological, eGFR,

albumin, hsCRP, TNF-a, IL-6

Diet and

nutrition

Nutrition screening (modified NSI), food frequency intake, 24-hour food

record, serum Hb, albumin, homocysteine, folate, B12,

Physical

function

Instrumental and basic ADL, Handgrip, knee extension strength, POMA-

Balance, POMA-Gait, Repeated Chair Rise, TUG, Fast Gait Speed Test; Total

Energy Expenditure, LASA Physical Activity Questionnaire

Health status Quality of Life (SF-12, EQ5D), 4-item Life Satisfaction scale, Successful

ageing

Psychological

Geriatric Depression Scale (15 items), SCID diagnoses of psychiatric

disorders; Sleep problems

Resilience, optimism, ageing perceptions, mortality salience

Neurocognitive

Subjective Memory and Cognitive Complaint, IQCODE, Mini Mental State

Examination (MMSE), NPI, MOCA, RBANS, Comprehensive Neurocognitive

Test Battery: RAVLT, VR, Digit Span, CRT, SDMT, CTT, BD, BNT, story recall),

Clinical Dementia Rating (CDR), Hatchinski, panel consensus diagnosis of

dementia

Biobank Genetic, inflammatory and immune and other ad hoc studies

Follow up

• Cognition

• Dementia

• Depression

• Physical

functioning

• Frailty

• IADL

• BADL

• Quality of life,

• Health service

use

• Mortality

Page 6: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

• Physical Disability

• Frailty, Sarcopenia,

• Malnutrition

• Multi-morbidities

• Dementia and

Cognitive Decline

• Depression

• Psychosocial

• Others

Major Health Needs of the Elderly

Problems Solutions

• Medical Care Interventions

• Health System

Organization

• Preventive Programmes

• Geronto-engineering

Page 7: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Gerontology Research Programme

Problems Studies

Observational Cohort Studies

– Singapore Longitudinal Ageing

Studies (SLAS)

– Collaborative Projects

Interventional Studies

– Community-Based Early Psychiatric

Interventional Strategies Studies

(CEPIS)

– Frailty Intervention Trial (FIT)

– Diabetes and Mild Cognitive

Impairment RCT

– COPD Psychological Intervention

Trial (COPD-PSY)

• Physical Disability

• Frailty, Sarcopenia,

• Malnutrition

• Multi-morbidities

• Dementia and

Cognitive Decline

• Depression

• Psychosocial

• Others

Page 8: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Ageing Biology

– Ageing biomarkers

Cognition and Dementia

– Dementia epidemiology

– Risk and Protective Factors

– Nutritional Factors

– Insulin resistance

Depression

– Physical comorbidity

– Community Interventions

Frailty and Sarcopenia

– Frailty phenotypes

– Immune ageing

– Nutrition, physical and

cognitive interventions

Successful ageing

– Models and phenotypes

– Work, Retirement and Living

Alone

Gerontology Research Programme

Themes Studies

Observational Cohort Studies

– Singapore Longitudinal Ageing

Studies (SLAS)

– Collaborative Projects

Interventional Studies

– Community-Based Early Psychiatric

Interventional Strategies Studies

(CEPIS)

– Frailty Intervention Trial (FIT)

– Diabetes and Mild Cognitive

Impairment RCT

– COPD Psychological Intervention

Trial (COPD-PSY)

Page 9: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Function

and Disability

Page 10: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

ADL Functional Disability

Page 11: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

ADL Functional Disability ADL Functional Disability

Risk Factors and Correlates OR

P<0.05

Age (vs 60-69)

70-79 4.4

80+ 13.6

Female gender 2.9

Indian ethnicity 2.1

Living with others 5.7

Poor-Fair self-rated health 3.5

Self-reported chronic condition

Arthritis 2.2

Urinary problems 4.6

Stroke 6.9

Asthma/ COPD 7.6

Hip fracture 34.9

Kidney failure 24.2

Cognitive functioning

MMSE 24+ 1.0

MMSE 19-23 4.7

MMSE ≤18 10.5

Hearing impairment 3.1

Visual impairment 2.5

Page 12: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Functional Disability Individual Trajectory

Baseline 1st Follow Up 2nd Follow Up

Page 13: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical

Limitations (Strength, Gait,

Balance)

Geriatric

Syndromes

Age,

Demographics

Depleting Biological Physiological

Psychological Reserves

Social Network

and Support

Daily Living

Activity

Restriction

Physical Built

Environment

Medical

Morbidities

Personal

Behavioral

Factors

Health and

Social Service

Support

Quality of Life

Levels of Investigations of Physical Functional Needs

Page 14: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Malnutrition in the elderly

• Common worldwide

• Factors:

− Loss of appetite

− Loss of taste

− Poor dentition

− Difficulty swallowing

− Poor absorption

− Chronic diseases

− Increased drugs use

− Reduced mobility

− Financial and physical inability to consume

fresh food

• Marginal or biochemical (‘subclinical’)

deficiencies may have significant health effects

Page 15: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Nutritional Status of SLAS Older Persons

DETERMINE Your Nutritional Health Checklist

Risk Factors N=2611

Have illness that change the kind/amount of food consumed 40.3%

Take 3 or more drugs a day 25.0%

Eat alone most of the time 14.5%

Eat few fruits/vegetable/milk products (less than once a day) 9.0%

Have tooth or mouth problems that make it hard to eat 5.2%

Without wanting, have lost or gained 4 kg in last 6 months 3.5%

Have 3 or more drinks of beer/liquor/wine almost every day 3.1%

Not always physically able to shop, cook and/or feed by self 2.6%

Eat fewer than 2 meals per day 2.3%

Not always having enough money to buy the food needed 2.1%

Weighted score:

0-2: Good nutritional status and Low risk

3-5: Moderate risk of poor nutrition

6+: High risk of poor nutrition

At risk of poor nutrition (score of 3 or more): 30%

Singapore Med J. 2007 Oct;48(10):911- 4

Page 16: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Nutritional Markers in SLAS Older Persons

%

Anemia (Hb <11 in women or Hb <12 in men) 4.7

Low lymphocyte counts (<1500/mL) 17.3

Low Albumin (<38 g/L) 1.9

Low B12 (<180 pmol/L) 5.1

Low folate (<7 in men or <9.5 nmol/L in women) 5.3

High total cholesterol (>=6.5mmol/L) 13.9

High triglyceride (>2.2mmol/L) 11.4

High LDL-cholesterol (>4.0mmol/L) 19.3

Low HDL-cholesterol (<1.0mmol/L) 10.7

Metabolic syndrome# 30.9

Page 17: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Functioning Malnutrition and Physical Functioning

Nutritional Risk Unpublished

Balance Gait IADL

Independence

Page 18: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Functioning

Anemic Not

Anemic 8.75

8.80

8.85

8.90

8.95

Ga

it S

co

re

Anemic Not

Anemic 21.5

22

22.5

23

23.5

24

Ba

lan

ce

Sco

re

Anemic Not

Anemic 0

5

10

15

20

25

30

Lo

we

r Lim

b S

tren

gth

Lower Limb Strength

Gait

Balance

Physical Functioning

Anemia

Malnutrition-Inflammation and Physical Functioning

Under-nutrition

Chronic diseases

Multi-morbidity

Chronic inflammation

Page 19: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Folate

Am J Clin Nutr 2012 96: 1362-1368.

Balance

Micronutrient Deficiency and Physical Functioning

Gait

Functional

Independence

Page 20: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty

• Common geriatric syndrome

• Often congruent with multi-morbidity, functional

disability and institutionalization

• Defined as multisystem declines in physiological

reserves

• Resulting in increased risk of dependency in activities of

daily living, hospitalization, institutionalization and dying

when exposed to stress

• Potentially reversible

Page 21: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty

Cardiovascular Health Study (CHS) criteria

1. Unintentional shrinking: BMI of <18.5 kg/m2 and/or

unintentional weight loss ≥10 pounds (4.5Kg) in the last 6

months.

2. Slowness: 6-meter fast gait speed test, lowest quintile by gender

and height

3. Weakness: leg muscle strength in kilograms, lowest quintile by

gender and BMI strata

4. Exhaustion: vitality questions in SF-12: “Did you feel worn out?”,

“Did you feel tired?”, “Did you have a lot of energy?”, (total scores

3 to 15), score of <10

5. Low activity: self-reported time (in hours) spent doing moderate

and vigorous activities per week, lowest quintile by gender

Categories:

• Robust: No components

• Pre-frail: 1 to 2 components

• Frail: 3 -5 components

Page 22: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty, Multi-morbidity and Adverse Outcomes

J Am Med Dir Assoc (Available online 17 April 2014)

Adverse Outcomes Robust

n=883

Pre-frail

N=712

Frail

N=90 P

Depressive symptoms % 0.8 2.8 10.0 <0.001

Cognitive impairment % 4.1 8.4 22.2 <0.001

Multi-morbidity (>5 ) % 17.8 27.4 52.2 <0.001

IADL disability % 5.0 11.0 26.7 <0.001

ADL Disability % 0.2 3.2 7.8 <0.001

Hospital admission % 4.5 5.9 10.0 0.033

Page 23: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty Factors

Factors

Robust

n=883

Pre-

frail

N=712

Frail

N=90

P

value

Age 75+ % 7.9 20.2 36.7 <0.001

Female % 64.1 64.2 67.8 0.66

No formal education % 15.1 26.1 34.4 <0.001

1-2 room public housing % 16.7 25.6 41.1 <0.001

Non-Chinese ethnicity % 9.0 12.6 14.4 0.010

Single, divorced, widowed % 29.0 39.3 52.2 <0.001

Living alone % 12.9 18.7 26.7 <0.001

Current smoking % 19.7 25.5 27.3 0.004

Daily alcohol drinking % 3.4 2.4 1.1 0.114

Page 24: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Factors Robust

n=883

Pre-frail

N=712

Frail

N=90

P

value

Cardiovascular disease % 5.7 10.5 15.6 <0.001

Hypertension % 58.1 63.8 80.0 <0.001

Diabetes % 17.1 23.9 31.1 <0.001

Stroke % 1.6 4.1 12.2 <0.001

Coronary heart disease % 3.2 4.5 7.8 0.028

Atrial Fibrillation % 2.2 4.4 4.4 0.016

Heart failure % 0.7 2.3 3.3 0.003

Cataracts/ glaucoma % 26.3 32.9 51.1 <0.001

Asthma/COPD % 3.2 6.2 11.1 <0.001

Arthritis % 13.5 15.7 20.0 0.063

Osteoporosis % 4.6 6.7 12.2 0.003

Gastrointestinal problems % 5.9 7.9 15.6 0.002

Chronic Kidney disease % 4.5 10.8 18.9 <0.001

Cancer % 2.6 2.3 6.7 0.29

Thyroid disease % 4.6 5.8 1.1 0.86

Physical Frailty Factors

Factors

Robust

n=883

Pre-

frail

N=712

Frail

N=90

P

value

Age 75+ % 7.9 20.2 36.7 <0.001

Female % 64.1 64.2 67.8 0.66

No formal education % 15.1 26.1 34.4 <0.001

1-2 room public housing % 16.7 25.6 41.1 <0.001

Non-Chinese ethnicity % 9.0 12.6 14.4 0.010

Single, divorced, widowed % 29.0 39.3 52.2 <0.001

Living alone % 12.9 18.7 26.7 <0.001

Current smoking % 19.7 25.5 27.3 0.004

Daily alcohol drinking % 3.4 2.4 1.1 0.114

Page 25: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty Factors

Factors Robust

n=883

Pre-frail

N=712

Frail

N=90

P

Poly-pharmacy(>5 drugs) 10.0 20.1 28.9 <0.001

Poor self-rated health 0.3 1.3 6.7 <0.001

Visual impairment 20.7 31.7 45.6 <0.001

Hearing impairment 1.7 4.1 3.3 0.012

FEV1/FVC <0.7 15.5 21.8 31.1 <0.001

Page 26: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Nutritional Robust

n=883

Pre-frail

N=712

Frail

N=90

P

Obesity (BMI ≥ 30) 5.1 7.4 13.3 0.002

High nutritional risk (NNS score≥3) 21.9 37.5 53.3 <0.001

Low albumin (<40 g/L) 8.8 13.2 18.9 <0.001

Low haemoglobin 34.9 41.0 47.8 0.002

Low total cholesterol 0~5.19mmol/L) 47.0 52.3 55.1 0.022

Physical Frailty Factors

Factors Robust

n=883

Pre-frail

N=712

Frail

N=90

P

Poly-pharmacy(>5 drugs) 10.0 20.1 28.9 <0.001

Poor self-rated health 0.3 1.3 6.7 <0.001

Visual impairment 20.7 31.7 45.6 <0.001

Hearing impairment 1.7 4.1 3.3 0.012

FEV1/FVC <0.7 15.5 21.8 31.1 <0.001

Page 27: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Lifestyle Intervention in Frail Elderly

Singapore

Frailty

Intervention

Trial (FIT)

Page 28: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 29: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 30: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 31: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 32: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 33: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 34: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 35: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 36: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 37: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Frailty is reversible

SLAS Frailty Intervention Trial (Manuscript in preparation)

-1

-0.5

0

0.5

1

1.5

2

2.5

3

0M 3M 6M 12M

Kn

ee

str

en

gth

, k

g c

ha

nge

fro

m b

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Strength

-1.2

-1

-0.8

-0.6

-0.4

-0.2

0

0.2

0M 3M 6M 12M

Fra

ily

Sco

re C

ha

nge

fro

m B

ase

lin

e

Nutrition

Cognition

Physical

Combination

Control

Frailty

Page 38: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Ongoing

SLAS Vaccination Study in Frail Older Persons

Page 39: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Cognitive Impairment and

Dementia

Page 40: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per cent

Dementia 2.2

MCI 19.9

Prevalence in 2004

Unpublished

Page 41: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per cent

Dementia 2.2

MCI 19.9

Aged 65 and above

per cent

Dementia 3.6

MCI 25.2

Prevalence in 2004

Unpublished

Page 42: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per cent

Dementia 2.2

MCI 19.9

Aged 65 and above

per cent

Dementia 3.6

MCI 25.2

Aged 75 and above

per cent

Dementia 8.3

MCI 31.6

Prevalence in 2004

Unpublished

Page 43: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per 100 p-y

Dementia 1.5

MCI 7.2

Incidence Rates 2004 - 2010

Unpublished

Page 44: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per 100 p-y

Dementia 1.5

MCI 7.2

Aged 65 and above

per 100 p-y

Dementia 2.5

MCI 9.6

Incidence Rates 2004 - 2010

Unpublished

Page 45: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Aged 55 and above

per 100 p-y

Dementia 1.5

MCI 7.2

Aged 65 and above

per 100 p-y

Dementia 2.5

MCI 9.6

Aged 75 and above

per 100 p-y

Dementia 5.9

MCI 13.2

Incidence Rates 2004 - 2010

Unpublished

Page 46: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Conversion Rates

per 100 p-y

55+ 1.35

65+ 1.79

75+ 3.12

MCI Conversion to Dementia, 2004 - 2010

Unpublished

Page 47: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

• Leading cause of functional disability

Population

attributable risk %

Cognitive impairment 19.0%

Arthritis 14.0%

J Am Ger Soc 2006; 54:21–29.

Cognitive Impairment

Page 48: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Neuropsychiatric morbidity is associated with increased hospitalization risk

1

0.58

0.93

2.48

0.00

0.50

1.00

1.50

2.00

2.50

3.00

None Dementia

only

Depression

only

Depression

and

Dementia

Int Psychogeriatr. 2006 Mar 16;:1-11

Relative Risk of Hospitalization for chronic Illnesses

Page 49: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Risk and Protective Factors

• Genetics: APOE-e4, TOMM40, CLU, PICALM, etc

• Demographic: Increasing age, female sex, ethnicity, low

education

• Lifestyle behavior: physical activity

• Social: isolation/engagement, marital status, active work

employment

• Cognitive: mental activities

• Psychological: depression

• Medical: head injury, medical conditions and drugs

• Vascular: smoking, obesity, hypertension, diabetes, insulin

resistance, metabolic syndrome

• Nutritional: folate, B12, omega-3 PUFA, anti-oxidants

Page 50: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Int Psychogeriatr. 2008, Jan:1-15

Physical, Social and Productive Activity

Page 51: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Nutrition

0.0

0.5

1.0

1.5

2.0

2.5

Yes No

Underweight and Chronic Illness

0.0

0.5

1.0

1.5

2.0

2.5

0-20% 21-40% 41-60% 61-80% 81-100%

20 Percentiles of Haemoglobin

0.0

0.5

1.0

1.5

2.0

2.5

0-20% 21-40% 41-60% 61-80% 81-100%

20 Percentiles of Albumin Low BMI with chronic disease

Anemia Low albumin,

Immediate Recall

Delay Recall

Verbal Learning

Forgetting %

Language

-0.2

-0.15

-0.1

-0.05

0

0.05

0.1

0.15

0.2

Global LanguageExecutive

Control Processing

Speed

Visuo-

construction-0.35

-0.25

-0.15

-0.05

0.05

Folate Homocysteine

Page 52: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Physical Frailty is associated with Increased Risk of Cognitive Impairment and Dementia

0

2

4

6

8

Robust Pre-Frail Frail

Incident Cognitive

Impairment Odd Ratio

0

2

4

6

Robust Pre-Frail Frail

Incident MCI-Dementia

Odd Ratio

Manuscript in review

Page 53: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Lifestyle Intervention in Frail Elderly

Singapore

Frailty

Intervention

Trial (FIT)

Page 54: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

0 -0.008

0.016

0

-0.028

-0.072

-0.1

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 MonthGlo

ba

l C

ogn

itio

n Z

-Sco

re C

ha

nge

Cognitive Control

p=0.754 p=0.189

Cognitive Training

• Cognitive and Combination Interventions Improves

Cognitive Functioning

Lifestyle Interventions in Frail Elderly

Manuscript in review

Page 55: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

0 -0.008

0.016

0

-0.028

-0.072

-0.1

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 MonthGlo

ba

l C

ogn

itio

n Z

-Sco

re C

ha

nge

Cognitive Control

p=0.754 p=0.189

Cognitive Training

• Cognitive and Combination Interventions Improves

Cognitive Functioning

Lifestyle Interventions in Frail Elderly

Manuscript in review

Page 56: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

0

0.069 0.062

0

-0.028

-0.072

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 Month

Glo

ba

l C

ogn

itio

n Z

-sco

re C

hn

age

Combination Control

p=0.129 p=0.05

0 -0.008

0.016

0

-0.028

-0.072

-0.1

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 MonthGlo

ba

l C

ogn

itio

n Z

-Sco

re C

ha

nge

Cognitive Control

p=0.754 p=0.189

Cognitive Training Combination

• Cognitive and Combination Interventions Improves

Cognitive Functioning

Lifestyle Interventions in Frail Elderly

Manuscript in review

Page 57: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

0

0.069 0.062

0

-0.028

-0.072

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 Month

Glo

ba

l C

ogn

itio

n Z

-sco

re C

hn

age

Combination Control

p=0.129 p=0.05

0 -0.008

0.016

0

-0.028

-0.072

-0.1

-0.08

-0.06

-0.04

-0.02

0

0.02

0.04

0.06

0.08

Baseline 6 Month 12 MonthGlo

ba

l C

ogn

itio

n Z

-Sco

re C

ha

nge

Cognitive Control

p=0.754 p=0.189

Cognitive Training Combination

• Cognitive and Combination Interventions Improves

Cognitive Functioning

Lifestyle Interventions in Frail Elderly

Manuscript in review

Page 58: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

DIABETES is associated with

Increased Risk of Cognitive Impairment and Dementia

0

5

10

15

DM- DM+

Prevalent Dementia Per 100

AOR=2.08, p=0.014

Unpublished

0

10

20

30

DM- DM+

Prevalent MCI

Per 100

AOR=1.30, p=0.036

Page 59: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

DIABETES is associated with

Increased Risk of Cognitive Impairment and Dementia

0

5

10

15

DM- DM+

Prevalent Dementia Per 100

AOR=2.08, p=0.014

Unpublished

0

10

20

30

DM- DM+

Prevalent MCI

Per 100

AOR=1.30, p=0.036

0

5

10

15

DM- DM+

Incident Dementia Per 100 py

AOR=2.15, p=0.002

0

10

20

30

DM- DM+

Incident MCI

Per 100

AOR=2.53 p=0.001

Page 60: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

No Yes 0

0.5

1

1.5

Metabolic Syndrome

Cognitive Decline

¶ Adjusted for age, gender, education, baseline

depressive symptoms (for whole sample),

hypertension, cardiovascular illness or stroke, other

medical co-morbidity, other anti-diabetic use,

APOE-4 carrier status, fasting blood glucose, BMI

and duration of diabetes.

Am J Geriatr Psychiatr (2008)

Cognitive Function METABOLIC SYNDROME is associated with

Increased Risk of Cognitive Decline and MCI

Page 61: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

No Yes 0

0.5

1

1.5

Metabolic Syndrome

Cognitive Decline

¶ Adjusted for age, gender, education, baseline

depressive symptoms (for whole sample),

hypertension, cardiovascular illness or stroke, other

medical co-morbidity, other anti-diabetic use,

APOE-4 carrier status, fasting blood glucose, BMI

and duration of diabetes.

Am J Geriatr Psychiatr (2008)

Association of MetS with Amnestic MCI Subgroups OR(95%CI) P

APOE-e4 Carrier 3.35 (1.03-10.8) 0.044

Non-APOE-ε4 carrier 1.54 (0.94-2.50) 0.084

APOE-ε4 Carrier and Age≥65 2.82 (0.60-13.3) 0.19

APOE-ε4 Carrier and Age<65 6.57 (1.03-41.7) 0.046

Non-APOE-ε4 Carrier and Age≥65 1.60 (0.86-2.97) 0.14

Non-APOE-ε4 Carrier and Age<65 1.48 (0.63-3.47) 0.36

Adjusted for age, gender, education, current smoking, alcohol drink, physical activity

score, heart disease or stroke, GDS score, APOE-ε4 allele carrying status

J Alzheim Dis 2013

Cognitive Function METABOLIC SYNDROME is associated with

Increased Risk of Cognitive Decline and MCI

Page 62: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Prediabetic and diabetic patients with mild cognitive impairment

Metformin and Intensive lifestyle

intervention

Randomization

Brain glucose hypometabilism (FDG-PET)

Cognitive function

Insulin Resistance and Mild Cognitive Impairment (MCI) in Older

Adults with Pre-Diabetes and Diabetes: Cognitive Effects of Lifestyle

Intervention and Metformin Treatment

National Medical Research Council NMRC CIRG12may033

Randomized controlled trial

Standard care

Page 63: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Depression

Page 64: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Critical Facts and Health Service Needs

• Under-diagnosed and under-treated

• The majority present to primary care physicians

instead of psychiatrist

• Sub-syndromal symptoms are equally disabling as

syndromic symptoms

• Powerfully impact on morbidity, health service use,

quality of life and mortality

Depression in the Elderly

Page 65: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Depressive symptoms (GDS≥5)………….12.9%

Case level depression ………………………..4.9%

Subcase level depression …………………..9.6%

Case and subcase depression …………….14.5%

Depression prevalence

Page 66: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Soh KC, Kumar R, Niti M, Kua EH, Ng TP. Subsyndromal depression in old age: clinical

significance and impact. International Psychogeriatrics (In Press).

Subsyndromal Depression

Acknowledge mental illness

Disabled for > 12 months

Perceived need

for help

Sought help of

professionals

Takes medications

0

5

10

15

20

25

30

Acknowledgemental illness

Disabled >12months

Perceivedneed for help

Sought help(Professional

Takesmedications

Non-Case Sub-Case Case

Percentage %

Page 67: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Health service use and depression

Non-depressed at baseline Depressive symptoms at 1 year follow up

% p Adjusted OR (95% C.I.) p

Hospitalized in past year

No (N=857) 1.6 1

Yes (N=68) 11.8 <0.001 10.2 (3.36 - 31.1) 0.0001

Physician visits in past year

≤5 visits (N=605) 0.8 <0.001 1

>5 visits (N=320) 5.3 7.37 (2.23 - 24.4) 0.0011

Int Psychogeriatr. 2009 Jun;21(3):568-75.

Page 68: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

International Psychogeriatrics 2008; Feb;20(1):188-200.

Depression increases with Multi-morbidity and

Disability

0

10

20

30

No chronicillness

1-2 chronicillnesses

≥3 chronic illnesses

% Depression

0

10

20

30

Nodisability

IADLdisability

Only

BADL w/woIADL

Disability

% Depression

Page 69: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

20

40

60

80

100

Admission Discharge 6 month 12 month

None

Cognitive

Impaired

Depressed

Cognitive-

Impaired and

Depressed

Barthel Index

Depression and Cognitive Impairment among Hip Fracture

Rehabilitation Inpatients

• Adversely Impact on Functional Recovery

International Psychogeriatrics 2010 Mar;22(2):246-53.

Page 70: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

0

2

4

6

8

10

12

14

16

18

20

Days

Not Depressed Depressed Not Depressed Depressed

Index

Hospitalization

Total

Hospitalization in

1 Year

Arch Intern Med. 2007 Jan 8;167(1):60-7.

Depression among COPD in-patients • Increases hospital stay

Page 71: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

10

20

30

40

50

60

70

80

90

Symptoms Activity Impact Total

SG

RQ

Mean S

core

s

Not Depressed Depressed

Higher SGRQ score denotes poor quality of life. Adjusted in model that included: Sociodemographic factors [age, gender, ethnicity, housing type, marital status, living arrangement]; Clinical factors [chronic mucus hypersecretion, BMI, comorbidity]; Disease severity markers [duration of COPD, No. of readmissions, dyspnea, FEV1% predicted]; Psychosocial and behavioural factors [anxiety, smoking, caregiver-family support]

P=0.006

P=0.019

P=0.012

P=0.002

Depression among COPD in-patients • is associated with Poorer Quality of Life 1 year post-

discharge

Page 72: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Depression among COPD in-patients • Increases post-hospital discharge mortality

Arch Intern Med. 2007 Jan 8;167(1):60-7.

Page 73: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

COPD Patients

Standard care

Depression screening,

Psychological

interventions

Randomization

COPD Outcomes FEV1

Exacerbations Hospitalization rates

Mortality

Consultation Liaison and Integrated Care for COPD patients

with Psychiatric Co-Morbidity

MOH Health Service Research HSRG0016/2010

Page 74: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Lifestyle Intervention in Frail Elderly

Singapore

Frailty

Intervention

Trial (FIT)

Page 75: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Nutrition Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Physical Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Cognitive Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Combination Control

Lifestyle Intervention in Frail Elderly

Page 76: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Nutrition Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Physical Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Cognitive Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Combination Control

Lifestyle Intervention in Frail Elderly

P=0.016

Page 77: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Nutrition Control

P=0.016

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Physical Control

P=0.026

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Cognitive Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Combination Control

Lifestyle Intervention in Frail Elderly

Page 78: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Nutrition Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Physical Control

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Cognitive Control

P=0.021

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Combination Control

Lifestyle Intervention in Frail Elderly

P=0.016 P=0.026

Page 79: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Nutrition Control

P=0.016

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Physical Control

P=0.026

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Cognitive Control

P=0.021

.1

.3

.5

.7

.9

0M 3M 6M 12M

Me

an

GD

S S

co

re

Combination Control

P=0.012 P=0.005

Lifestyle Intervention in Frail Elderly

Page 80: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

• Primary care outreach:

– Aims to improve access and use of mental

health services

– Depression/ Anxiety screening and case finding

– Assessment and Referral

• Integrated collaborative care:

– Aims to improve quality of care

– Consultation and treatment in non-

institutionalized community and non-psychiatric

settings

– Treatment algorithms or protocols

– Integrated and collaborative care arrangements

Innovations and models of care

Page 81: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

• Community-Based Early Psychiatric

Interventional Strategy (CEPIS) programme in

Singapore

• Island-wide community-based outreach

service and collaborative care model

• Aimed at improving access and treatment

outcomes for depression among the elderly in

Singapore

CEPIS

Page 82: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical
Page 83: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

CEPIS

1. Community-wide outreach through neighbourhood social

service centres for seniors;

2. Active case detection: routine screening of depressive

symptoms

3. Psychoeducation and counseling by trained nurse

educators to accept treatment

4. Primary care treatment by trained general practitioners

in neighbourhoods

5. Case manager support

Page 84: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

CEPIS

• Seniors GDS≥5 were randomized to collaborative care or

usual care

• Primary care-centered treatment

• Integrated structured collaborative shared care

framework

• GPs were trained in primary care treatment of late life

depression, according to treatment algorithm and

flexible management protocol

• Support from a case manager and nurse educator

• Consultation liaison and referral to psychotherapist or

psychiatrist

Page 85: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Outreach sites

• 42 social service sites (‘community services

centers’, ‘senior activities centers’, ‘elderly care

corners’)

• 18 special needs services (social day care

center, rehabilitation center)

• 12 sheltered and welfare home facilities

• 4 nursing homes

Page 86: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Outreach participants

• 4633 participants

• Mean age was 73.7 (SD,7.9)

• 58% were women

• 89% were Chinese

• 51% had no formal education

• 45% were separated, divorced or widowed

• 64% resided in low-end public housing apartments,

welfare, sheltered homes

• 29% lived alone

• 36% reported having 3 or more chronic medical

diseases.

Page 87: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Depression

• 370 (8%) screened positive for depressive symptoms

• 151 (40.8%) major depressive disorder

• 69 cases comorbid disorders

• Less than 25% reported having a mental disorder, or poor

mental health, or perceived need for help

• Only 38 (10.3%) had spontaneously sought treatment for

mental problems in the past year

Page 88: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Outreach results

• Nurses’ visits and follow-through psychoeducation

• 273 (73.8%) of seniors with depressive symptoms

were successfully referred to a GP for further

assessment and treatment.

• Pre-outreach treatment seeking was 10.3%

Page 89: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

Page 90: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

Page 91: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

Page 92: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

-10

-8

-6

-4

-2

0

0M 3M 6M 12M

BDI Change from Baseline

NC UC CC

Page 93: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

-10

-8

-6

-4

-2

0

0M 3M 6M 12M

BDI Change from Baseline

NC UC CC

Page 94: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-5

-4

-3

-2

-1

0

0M 3M 6M 12M

GDS Change from Baseline

NC UC CC

-10

-8

-6

-4

-2

0

0M 3M 6M 12M

BDI Change from Baseline

NC UC CC

Page 95: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

Page 96: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

Page 97: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

Page 98: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

0

2

4

6

8

0M 3M 6M 12M

MCS Change from Baseline

NC UC CC

Page 99: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

0

2

4

6

8

0M 3M 6M 12M

MCS Change from Baseline

NC UC CC

Page 100: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

-4

-3

-2

-1

0

0M 3M 6M 12M

HDRS Change from Baseline

NC UC CC

0

2

4

6

8

0M 3M 6M 12M

MCS Change from Baseline

NC UC CC

Page 101: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Collaborative Care Results

Treatment and care satisfaction Usual

Care

Collaborative

Care p

Primary care doctor’s diagnosis of depression 53.6 56.9 0.63

Any anti-depressant use 27.5 34.5 0.30

Psychiatrist referral 2.1 1.2 0.66

Psychotherapist referral 1.0 4.8 0.12

Social worker 10.9 9.4 0.74

Patient satisfaction questionnaire survey, N* 93 92

Understanding your problem or illness 6.6 15.1 0.001

Advice about how to cope with your problem and illness 4.3 21.7 0.001

Doctor’s management of your health problem 5.4 19.4 0.002

Having access to specialist help if you need it 3.2 8.6 0.004

The amount of money you have to pay 26.9 26.1 0.80

The practical support to continue your road to recovery 8.6 16.3 <0.001

Relieving your pain and suffering 4.3 18.5 0.004

Recovering from your emotional and mental distress 4.3 19.6 <0.001

Returning to your normal activities 3.2 15.2 0.002

Overall care and help 12.9 28.3 0.02

Page 102: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Grant funding support

A*STAR Biomedical Research Council

• 03/1/21/17/214: Gerontology Research Programme : Biological, Clinical, Psychosocial And Behavourial Predictors Of

Health Status In Prospectively Followed-Up Cohorts Of Elderly Persons

• SIgN 10-036: Immune Signatures and Biomarker Profiling of Frailty

Ministry of Health National Medical Research Council

• NMRC/0846/2004: Randomised Controlled Trial Of A Community-Based Early Psychiatric Intervention Strategy To Screen

And Manage Depression In The Elderly

• NMRC/1108/2007: Randomized Controlled Trial of Community-based Nutritional, Physical and Cognitive Training

Intervention Programmes for At Risk Frail Elderly

• NMRC/08/1/21/19/567: Gerontology Research Programme: Nutritional, cardiometabolic and vascular factors, ApoE4

gene interactions, and dementia and depression risk”

• CIRG12may033: Insulin Resistance and Mild Cognitive Impairment (MCI) in Older Adults with Pre-Diabetes and Diabetes:

Cognitive Effects of Lifestyle Intervention and Metformin Treatment in a Randomized Controlled Trial

• HSRG0016/2010 : Consultation Liaison and Integrated Care for COPD patients with Psychiatric Co-Morbidity

National University Health System, National University of Singapore,

• AIRC R-177-000-031-133: The built environment and quality of life of older persons

• NUHSRO/2011/009/STB/B2B-05: Levels and activities of sirtuins in peripheral blood cells as biomarkers for healthy

ageing and ageing disorders

Venerable Yen Pei-National Kidney Foundation Research Fund

• NKFRC/2010/07/16Mood,cognitive, physical functioning and quality of life in older adults with chronic kidney disease

Alice Lim Memorial Fund

• R-177-000-030-290: The Association between diet & health status in Asian Elderly

Anonymous Donor

R-177-000-028-720. Successful Ageing: Characterizing its Multiple Dimensions in Singaporean Seniors and the

Development and Validation of a Measurement Scale for Health Care and Promotion Programmes.

Page 103: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Voluntary Welfare Organizations Support

• Geylang East Home for the Aged,

• Presbyterian Community Services,

• Thye Hua Kwan Moral Society (Moral Neighbourhood Links),

• Henderson Senior Citizens’ Home, NTUC Eldercare Co-op Ltd,

• Thong Kheng Seniors Activity Centre (Queenstown Centre)

• Redhill Moral Seniors Activity Centre.

ACKNOWLEDGEMENTS

Collaborators

A/Prof Ng Tze Pin (PI), A/Prof Yap Keng Bee, A/Prof Lee Tih Shih, A/P Lim Su Chi

A/Prof Fong Ngan Phoon , Prof Kua Ee Heok, A/Prof Tan Chay Hoon

Dr Tong Yoke Yin Terry, Dr Yap Lin Kiat Philip, Dr Tan Boon Yeow

Dr Chong Mei Siang, Dr Lim Wee Shiong, Dr Feng Lei

Dr Simon Lowes Collinson, Dr Anis Larbi,

Prof Bengt Winblad, Prof Laura Fratigliori

Page 104: Observational Cohort and Interventional Studies · 2018-07-11 · – Community Interventions Frailty and Sarcopenia – Frailty phenotypes – Immune ageing – – Nutrition, physical

Thank You